How Ritlecitinib Revolutionizes Alopecia Treatment
Alopecia areata, an autoimmune condition leading to hair loss, finds promising treatment options in ritlecitinib. This targeted immune therapy, now FDA-approved, shows significant efficacy through inhibiting inflammatory cycles, with ongoing research broadening its application to other autoimmune disorders. Understanding its mechanism and safety is crucial for managing these often challenging conditions. Understanding Ritlecitinib in Alopecia […]
3 minute read